Tikun Olam-Cannbit Pharmaceuticals Ltd's (TLV:TKUN) Popularity With Investors Under Threat As Stock Sinks 26%
Dec 02
Have your own idea? Try our Stock Screener
Israeli (TA) Pharma Industry Analysis
UpdatedDec 19, 2024
DataAggregated Company Financials
Companies9
- 7D1.8%
- 3M-11.9%
- 1Y-12.1%
- YTD-12.8%
Over the last 7 days, the Pharma industry has risen 1.9%, driven by gains from InterCure of 2.7%. In contrast, the industry has lost 10.0% in the last 12 months.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 19 Dec 2024 | ₪636.6m | ₪828.6m | -₪180,465,349.40 | 21x | -3.5x | 0.8x |
| Sat, 16 Nov 2024 | ₪590.1m | ₪816.0m | -₪200,862,110.50 | 24.1x | -2.9x | 0.7x |
| Mon, 14 Oct 2024 | ₪654.3m | ₪808.7m | -₪205,828,142.90 | 23.8x | -3.2x | 0.8x |
| Wed, 11 Sep 2024 | ₪712.9m | ₪810.4m | -₪244,606,431.30 | 23.6x | -2.9x | 0.9x |
| Fri, 09 Aug 2024 | ₪643.9m | ₪901.7m | -₪263,686,302.40 | n/a | -2.4x | 0.7x |
| Sun, 07 Jul 2024 | ₪695.9m | ₪901.7m | -₪261,995,666.00 | n/a | -2.7x | 0.8x |
| Tue, 04 Jun 2024 | ₪835.7m | ₪886.2m | -₪255,610,813.20 | n/a | -3.3x | 0.9x |
| Thu, 02 May 2024 | ₪863.4m | ₪956.4m | -₪180,534,652.00 | 25.1x | -4.8x | 0.9x |
| Sat, 30 Mar 2024 | ₪777.1m | ₪972.3m | -₪208,882,296.00 | 20.8x | -3.7x | 0.8x |
| Mon, 26 Feb 2024 | ₪653.3m | ₪972.3m | -₪212,022,859.30 | 14.7x | -3.1x | 0.7x |
| Wed, 24 Jan 2024 | ₪561.9m | ₪972.3m | -₪214,708,392.00 | 11x | -2.6x | 0.6x |
| Fri, 22 Dec 2023 | ₪578.6m | ₪972.3m | -₪211,885,950.00 | 10.3x | -2.7x | 0.6x |
| Sun, 19 Nov 2023 | ₪579.6m | ₪958.8m | -₪207,826,763.00 | 10x | -2.8x | 0.6x |
| Tue, 17 Oct 2023 | ₪642.7m | ₪958.8m | -₪213,742,191.00 | 11.4x | -3x | 0.7x |
| Thu, 14 Sep 2023 | ₪673.2m | ₪958.8m | -₪210,107,862.00 | 13.4x | -3.2x | 0.7x |
| Sat, 12 Aug 2023 | ₪655.5m | ₪918.8m | -₪127,258,837.00 | 8.4x | -5.2x | 0.7x |
| Mon, 10 Jul 2023 | ₪655.3m | ₪918.8m | -₪126,423,431.00 | 8.4x | -5.2x | 0.7x |
| Wed, 07 Jun 2023 | ₪756.2m | ₪912.7m | -₪126,824,636.00 | 10.4x | -6x | 0.8x |
| Fri, 05 May 2023 | ₪809.8m | ₪887.2m | -₪121,794,034.00 | 8x | -6.6x | 0.9x |
| Sun, 02 Apr 2023 | ₪764.0m | ₪829.2m | -₪97,816,963.00 | 10.9x | -7.8x | 0.9x |
| Tue, 28 Feb 2023 | ₪903.3m | ₪815.6m | -₪72,330,558.00 | 13.3x | -12.5x | 1.1x |
| Thu, 26 Jan 2023 | ₪1.0b | ₪739.7m | -₪54,717,188.00 | 16.9x | -18.5x | 1.4x |
| Sat, 24 Dec 2022 | ₪1.1b | ₪739.7m | -₪57,339,450.00 | 18.6x | -18.3x | 1.4x |
| Mon, 21 Nov 2022 | ₪1.3b | ₪728.3m | -₪56,869,050.00 | 23.5x | -22.7x | 1.8x |
| Wed, 19 Oct 2022 | ₪1.3b | ₪689.4m | -₪60,617,329.00 | 32x | -21.4x | 1.9x |
| Fri, 16 Sep 2022 | ₪1.4b | ₪785.2m | -₪111,018,599.00 | 29.1x | -12.2x | 1.7x |
| Sun, 14 Aug 2022 | ₪1.6b | ₪731.4m | -₪114,950,081.00 | 45.4x | -14.3x | 2.2x |
| Tue, 12 Jul 2022 | ₪1.6b | ₪731.4m | -₪119,705,068.00 | 45x | -13.3x | 2.2x |
| Thu, 09 Jun 2022 | ₪1.7b | ₪731.4m | -₪117,253,623.00 | 42.1x | -14.8x | 2.4x |
| Sat, 07 May 2022 | ₪1.7b | ₪669.4m | -₪124,277,672.00 | 36.8x | -13.7x | 2.5x |
| Mon, 04 Apr 2022 | ₪2.0b | ₪609.9m | -₪107,259,949.00 | 39.6x | -18.2x | 3.2x |
| Wed, 02 Mar 2022 | ₪1.8b | ₪598.9m | -₪111,389,112.00 | 46.9x | -16.5x | 3.1x |
| Fri, 28 Jan 2022 | ₪1.8b | ₪598.9m | -₪96,977,854.00 | 48.2x | -18.7x | 3x |
| Sun, 26 Dec 2021 | ₪1.9b | ₪559.8m | -₪169,871,034.00 | 50.5x | -11.3x | 3.4x |
Price to Earnings Ratio
-11.3x
Current Industry PE
- Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 1.4x is higher than the industry's current PS ratio of 0.76x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 14% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | 0.24% | |
| Healthcare | -0.94% | |
| Pharma | 1.76% | |
| Pharma | 1.76% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| INCR InterCure | ₪5.17 | 4.5% +₪10.1m | 9.9% | PS0.9x | |
| SEMG Seach Medical Group | ₪3.14 | 4.1% +₪4.2m | 73.9% | PS0.6x | |
| REKA Rekah Pharmaceutical Industry | ₪14.00 | 0.9% +₪1.5m | -8.3% | PE21x | |
| BARI Barak Investment House | ₪45.38 | 1.8% +₪413.8k | n/a | n/a | |
| PMCN-M Pharmocann Global | ₪1.81 | 0.5% +₪28.9k | 9.1% | PS0.4x |